By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Selecta Biosciences, Inc. 

480 Arsenal Street
Building One
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-923-1400 Fax: 617-924-3454


Company News
Lyophilization Services of New England Contract Manufacturing Announces Manufacturing Agreement With Selecta (SELB) 5/24/2017 8:14:23 AM
Selecta (SELB) Announces First Quarter 2017 Financial Results And Provides Corporate Update 5/12/2017 12:32:34 PM
Selecta (SELB) Commences Dosing In Phase I Clinical Trial Of Nicotine Vaccine For Smoking Cessation And Relapse Prevention 5/12/2017 11:27:51 AM
Selecta (SELB) To Report First Quarter 2017 Financial Results On Thursday, May 11, 2017 5/4/2017 10:45:16 AM
Selecta (SELB) Obtains License For Recombinant Immunotoxin LMB-100 From NCI) For Pancreatic Cancer, Mesothelioma And Other Cancers 5/2/2017 10:13:18 AM
Selecta (SELB) Presents Preclinical Data Regarding SVP-Enabled Peanut Allergy Therapeutic Vaccine And Celiac Disease Treatment 2/6/2017 7:58:09 AM
Massachusetts' Selecta (SELB) Wrangles $890 Million+ R&D Deal Out of Spark Therapeutics (ONCE) 12/5/2016 5:44:25 AM
Selecta (SELB) Collaborators At The National Cancer Institute Present Preclinical Data Showing SVP-Rapamycin Application To Cancer Therapy 10/31/2016 9:06:20 AM
Selecta (SELB) Announces Second Quarter 2016 Financial Results And Provides Corporate Update 8/9/2016 8:36:32 AM
Selecta (SELB) Announces Gene Therapy Programs For Two Rare Genetic Metabolic Disorders 7/19/2016 9:20:34 AM